In PCa, higher METTL14 expression has been correlated with poor prognosis in PCa patients, with knockdown of METTL14 attenuating tumour proliferation both in vitro and in vivo (Wang et al., 2022). Here, METTL14 is linked to posterior cortical atrophy.